Table 2.
Meta-analysis of the 15 studies* stratified by the HPV detection method
| Detection method | No. of studies | Events | Sample size | Point estimates of event rates (fixed effects model) | Point estimates of event rates (random effects model) | Homogeneity (Cochran's Q)** | I-squared (I2)** | Homogeneity (p-value)** | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
| Point estimate | 95% CI | Point estimate | 95% CI | |||||||
| IHC | 1 | 2 | 2 | 0.833 | 0.194–0.990 | 0.833 | 0.194–0.990 | 0.000 | 0.000 | 1.000 |
| ISH | 9 | 16 | 36 | 0.478 | 0.268–0.697 | 0.534 | 0.232–0.812 | 16.317 | 50.971 | 0.038 |
| PCR | 5 | 20 | 51 | 0.384 | 0.259–0.526 | 0.391 | 0.252–0.549 | 4.305 | 7.082 | 0.366 |
| Summary | 15 | 38 | 89 | 0.422 | 0.311–0.542 | 0.434 | 0.302–0.575 | 22.690 | 38.300 | 0.065 |
| Total within (FE) | 20.622 | 0.056 | ||||||||
| Total between (FE) | 2.069 | 0.355 | ||||||||
| Total between (RE) | 2.112 | 0.348 | ||||||||
All studies reporting only bronchial carcinomas are omitted;
only calculated for fixed effects model
IHC – immunohistochemistry, ISH – in situ hybridization, PCR – polymerase chain reaction, FE – fixed effects model, RE – random effects model